At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01066 WEIGAO GROUP
Not Yet Opened 03-24 16:08:17
5.190
-0.010
-0.19%
High5.270Low5.040Vol7.74M
Open5.110D1 Closing5.200Amplitude4.42%
Mkt Cap23.71BTradable Cap23.46BTotal Shares4.57B
T/O39.91MT/O Rate0.17%Tradable Shares4.52B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Pinning Down Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) P/E Is Difficult Right Now
Simply Wall St.  ·  03-10
Pinning Down Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) P/E Is Difficult Right Now
Wego and the Egyptian Tourism Authority Announce Strengthened Partnership to Showcase Egypt's Timeless Wonders
THOMSON REUTERS  ·  03-04
Wego and the Egyptian Tourism Authority Announce Strengthened Partnership to Showcase Egypt's Timeless Wonders
Wego and Jordan Tourism Board Join Forces to Inspire Global Travelers to Discover Jordan's Wonders
THOMSON REUTERS  ·  02-24
Wego and Jordan Tourism Board Join Forces to Inspire Global Travelers to Discover Jordan's Wonders
Shandong Weigao Group Medical Polymer Repurchases Shares Worth HK$5 Million
MT Newswires Live  ·  02-21
Shandong Weigao Group Medical Polymer Repurchases Shares Worth HK$5 Million
Shandong Weigao Group Medical Polymer Repurchase 50,000 Shares
MT Newswires Live  ·  02-12
Shandong Weigao Group Medical Polymer Repurchase 50,000 Shares
Both private companies who control a good portion of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) along with institutions must be dismayed after last week's 4.2% decrease
Simply Wall St.  ·  01-13
Both private companies who control a good portion of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) along with institutions must be dismayed after last week's 4.2% decrease
Shandong Weigao Group Medical Polymer (HKG:1066) stock falls 8.4% in past week as three-year earnings and shareholder returns continue downward trend
Simply Wall St.  ·  2024-12-17
Shandong Weigao Group Medical Polymer (HKG:1066) stock falls 8.4% in past week as three-year earnings and shareholder returns continue downward trend
BRIEF-Shandong Weigao Group Medical Polymer Announces 7-Year Long-Term Loan Facilities
Reuters  ·  2024-12-06
BRIEF-Shandong Weigao Group Medical Polymer Announces 7-Year Long-Term Loan Facilities
Shandong Weigao Group Medical Polymer - Loans With Aggregated Principal Amount of $250 Mln
THOMSON REUTERS  ·  2024-12-06
Shandong Weigao Group Medical Polymer - Loans With Aggregated Principal Amount of $250 Mln
Shandong Weigao Group Medical Polymer - Seven-Year Long-Term Loan Facilities
THOMSON REUTERS  ·  2024-12-06
Shandong Weigao Group Medical Polymer - Seven-Year Long-Term Loan Facilities
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
Simply Wall St.  ·  2024-11-26
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital
Simply Wall St.  ·  2024-11-04
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital
Be Sure To Check Out Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Before It Goes Ex-Dividend
Simply Wall St.  ·  2024-10-14
Be Sure To Check Out Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Before It Goes Ex-Dividend

Introduction

Company Name.
WEIGAO GROUP
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of single-use medical devices. The Company operates six segments. Medical Device Products segment engaged in the production and sale of clinical care, medical testing, anesthesia and surgical related products and other consumables. Orthopaedic Products segment engaged in the production and sale of orthopaedic products, including tissue repair product line. Interventional Products segment engages in production and sale of tumor and blood vessel interventional instruments. Pharma Packaging Products segment includes production and sale of pre-filled syringes and flushing syringes. Blood Management Products segment includes production and sale of blood collection, irradiation, storage, separation and sterilization products. Others segment includes finance lease and factoring business.
Issue price:
--
Invest in Global Markets with Tiger Brokers!
Open App